Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04526509
Title Master Protocol to Assess Safety and Dose of First Time in Human Next Generation Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | DEU | CAN | AUS

Facility Status City State Zip Country Details
GSK Investigational Site New Haven Connecticut 06504 United States Details
GSK Investigational Site Jacksonville Florida 32224 United States Details
GSK Investigational Site Tampa Florida 33612 United States Details
GSK Investigational Site Atlanta Georgia 30322 United States Details
GSK Investigational Site Westwood Kansas 66205 United States Details
GSK Investigational Site Lexington Kentucky 40536 United States Details
GSK Investigational Site Baltimore Maryland 21287 United States Details
GSK Investigational Site Saint Louis Missouri 63110 United States Details
GSK Investigational Site New York New York 10032 United States Details
GSK Investigational Site New York New York 10065 United States Details
GSK Investigational Site Philadelphia Pennsylvania 19111 United States Details
GSK Investigational Site Houston Texas 77030 United States Details
GSK Investigational Site Melbourne Victoria 3000 Australia Details
GSK Investigational Site Toronto Ontario M5G 2M9 Canada Details
GSK Investigational Site Montreal Quebec H1T 2M4 Canada Details
GSK Investigational Site Muenchen Bayern 81377 Germany Details
GSK Investigational Site Hannover Niedersachsen 30625 Germany Details
GSK Investigational Site Koeln Nordrhein-Westfalen 50937 Germany Details
GSK Investigational Site Dresden Sachsen 01307 Germany Details
GSK Investigational Site Amsterdam 1066 CX Netherlands Details
GSK Investigational Site Stockholm SE-171 64 Sweden Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field